Amanda Beras
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 7
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Natasha Rekhtman (6 shared papers)William D. Travis (3 shared papers)Charles M. Rudin (6 shared papers)Jennifer L. Sauter (4 shared papers)Jacklynn V. Egger (5 shared papers)Joseph Montecalvo (3 shared papers)Jason C. Chang (4 shared papers)W. Victoria Lai (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Thoracic Oncology (2 papers)Annals of Oncology (1 paper)Modern Pathology (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Amanda Beras
6 papers receiving 605 citations
Amanda Beras's Hit Papers
Peers
Comparison fields: 5 of 37
- Oncology 443
- Epidemiology 227
- Neurology 64
- Pulmonary and Respiratory Medicine 134
- Cancer Research 44
Countries citing papers authored by Amanda Beras
This map shows the geographic impact of Amanda Beras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Beras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Beras more than expected).
Fields of papers citing papers by Amanda Beras
This network shows the impact of papers produced by Amanda Beras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Beras. The network helps show where Amanda Beras may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Beras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization Hit paper breakdown → | 2020 | 319 |
| 2 | 2020 | 225 | |
| 3 | 2019 | 60 | |
| 4 | 2019 | 2 | |
| 5 | 2019 | 2 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 0 |
About Amanda Beras
Amanda Beras is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Pathology and Forensic Medicine, having authored 7 papers that have together received 609 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Mechanisms and Therapy (1 paper), Cancer Genomics and Diagnostics (1 paper) and Chromatin Remodeling and Cancer (1 paper). The work is most often cited by research in Oncology (443 citations), Epidemiology (227 citations), Neurology (64 citations), Pulmonary and Respiratory Medicine (134 citations) and Cancer Research (44 citations). Amanda Beras has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Natasha Rekhtman, William D. Travis, Charles M. Rudin, Jennifer L. Sauter, Jacklynn V. Egger, Joseph Montecalvo, Jason C. Chang, W. Victoria Lai, John T. Poirier and Achim A. Jungbluth. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.